Litigation Details for Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. (Fed. Cir. 2023)
✉ Email this page to a colleague
Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. (Fed. Cir. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-06-20 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 10,143,693; 9,439,906 | ||
| Link to Docket | External link to docket | ||
Details for Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. (Fed. Cir. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-03-11 | 22 | launch. [1] From U.S. Patent No. 10,143,693; https://patents.google.com/patent/US10143693B2/en?oq=10%…-7 and 9-14 of United States Patent No. 10,143,693 (“the ’693 patent”) and Mylan’s products that are…Hatch-Waxman case involving Janssen’s U.S. Patent No. 10,143,693 (the “693 Patent”), listed in the Orange Book for…Claims 1-3, 5-7, and 9-29 of U.S. Patent No. 10,143,693 (the “693 Patent”). 15. It … “Plaintiffs”) concerning U.S. Patent No. 10,143,693 (“the ’693 patent”). In their Disclosures of Asserted | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
